Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources
November 18 2022 - 7:00AM
Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX:
TLRY), a leading global cannabis company inspiring and empowering
the worldwide community to live their very best life, today
announced that its medical cannabis division, Tilray Medical, has
launched
Take Back Control, a new
platform developed to connect women with free resources on medical
cannabis and to help destigmatize the use of medical cannabis in
women’s healthcare practices. The
Take Back
Control platform connects people with free consultations
with healthcare practitioners focused on women’s health providing
expert advice on medical cannabis.
Take Back Control is designed to help women make
informed decisions about medical cannabis and assists them along
their path to discovering how medical cannabis can play a part in
their daily healthcare practices. Available now in Canada, Take
Back Control simplifies the steps to meet with a healthcare
practitioner to help women through their needs and challenges,
providing professional guidance to help kick-start their medical
cannabis health care journey.
Tilray Medical is the recognized global leader in
medical cannabis and is committed to helping people take back
control of their healthcare choices and treatment. Unlike some
other alternatives, medical cannabis lets people become an active
participant in their healthcare journey.
For more information on Take Back Control visit
www.takebackcontrolnow.ca
About Tilray Medical Tilray
Medical is dedicated to transforming lives and fostering dignity
for patients in need through safe and reliable access to a global
portfolio of medical cannabis brands, including Tilray, Aphria,
Broken Coast, and Symbios. Tilray grew from being one of the first
companies to become an approved licensed producer of medical
cannabis in Canada to building the first EU-GMP-certified cannabis
production facilities in Europe, first in Portugal and later in
Germany. Today, Tilray Medical is one of the biggest suppliers of
medical cannabis brands to patients, physicians, hospitals,
pharmacies, researchers, and governments, in 20 countries and
across five continents.
For more information on Tilray Medical,
visit Tilray Medical Canada, Tilray Medical
Australia, Tilray Medical Australia-New Zealand, Tilray
Medical Europe
About Tilray BrandsTilray Brands,
Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global
cannabis-lifestyle and consumer packaged goods company with
operations in Canada, the United States, Europe, Australia, and
Latin America that is changing people's lives for the better – one
person at a time. Tilray Brands delivers on this mission by
inspiring and empowering the worldwide community to live their very
best life and providing access to products that meet the needs of
their mind, body, and soul while invoking wellbeing. Patients and
consumers trust Tilray Brands to deliver a cultivated experience
and health and wellbeing through high-quality, differentiated
brands and innovative products. A pioneer in cannabis research,
cultivation, and distribution, Tilray’s unprecedented production
platform supports over 20 brands in over 20 countries, including
comprehensive cannabis offerings, hemp-based foods, and craft
beverages.
For more information on how we open a world of
well-being, visit www.Tilray.com and follow @Tilray on
Instagram and Twitter.
Forward-Looking StatementsCertain
statements in this communication that are not historical facts
constitute forward-looking information or forward-looking
statements (together, “forward-looking statements”) under Canadian
securities laws and within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that are intended to
be subject to the “safe harbor” created by those sections and other
applicable laws. Forward-looking statements can be identified by
words such as “forecast,” “future,” “should,” “could,” “enable,”
“potential,” “contemplate,” “believe,” “anticipate,” “estimate,”
“plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and
the negative of these terms or similar expressions, although not
all forward-looking statements contain these identifying words.
Certain material factors, estimates, goals, projections, or
assumptions were used in drawing the conclusions contained in the
forward-looking statements throughout this communication.
Forward-looking statements include statements regarding our
intentions, beliefs, projections, outlook, analyses, or current
expectations concerning, among other things: expectations regarding
the performance and scale of the Company, including Tilray Medical;
and the Company’s ability to expand its offering to patients
worldwide, including via Tilray Medical. Many factors could cause
actual results, performance, or achievement to be materially
different from any forward-looking statements, and other risks and
uncertainties not presently known to the Company or that the
Company deems immaterial could also cause actual results or events
to differ materially from those expressed in the forward-looking
statements contained herein. For a more detailed discussion of
these risks and other factors, see the most recently filed annual
information form of Tilray and the Annual Report on Form 10-K (and
other periodic reports filed with the SEC) of Tilray made with the
SEC and available on EDGAR. The forward-looking statements included
in this communication are made as of the date of this communication
and the Company does not undertake any obligation to publicly
update such forward-looking statements to reflect new information,
subsequent events, or otherwise unless required by applicable
securities laws.
For further information:
Media
Kaitlin Macapagal
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Tilray Brands (TSX:TLRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tilray Brands (TSX:TLRY)
Historical Stock Chart
From Apr 2023 to Apr 2024